e-learning
resources
Berlin 2008
Tuesday, 07.10.2008
Biomarkers and disease assessment in COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
General metabolic intoxication in patients with COPD. Dynamics of metabolic intoxication severity on a background of tiotropium bromide (TB) treatment
T. Pertseva, O. Gurzhiy, O. Lykholat (Dnepropetrovsk, Ukraine)
Source:
Annual Congress 2008 - Biomarkers and disease assessment in COPD
Session:
Biomarkers and disease assessment in COPD
Session type:
E-Communication Session
Number:
3116
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Pertseva, O. Gurzhiy, O. Lykholat (Dnepropetrovsk, Ukraine). General metabolic intoxication in patients with COPD. Dynamics of metabolic intoxication severity on a background of tiotropium bromide (TB) treatment. Eur Respir J 2008; 32: Suppl. 52, 3116
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Effect of tiotropium bromide on IFN-γ level: Results from 180-days study in moderate COPD patients with viral-induced exacerbations in anamnesis
Source: International Congress 2016 – Preclinical pharmacology: drug targets and mechanisms of action
Year: 2016
Efficacy of tiotropium bromide inhalation combined with or without low dose theophylline for moderate to severe stable Chinese COPD patients
Source: Annual Congress 2013 –Asthma and COPD drugs: efficacy, safety and pharmacoeconomics
Year: 2013
The effect of tiotropium bromide on lung function parameters in patients with asthma- COPD overlap syndrome
Source: International Congress 2016 – Asthma points to ponder
Year: 2016
Response to the combined therapy in COPD patients (pts) with different plasma surfactant protein D (SPD) level
Source: International Congress 2014 – COPD markers
Year: 2014
Effect of tiotropium bromide on collagen-IV level: Results from 180-days study in subjects with moderate COPD
Source: International Congress 2014 – Markers
Year: 2014
Estimation of tiotropium efficacy at the COPD patients with group D
Source: International Congress 2015 – Different data in COPD
Year: 2015
Clinical effectiveness of antidepressive drug in patients with COPD and concomitant moderate depressive episode
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013
Effect of exacerbation history and ICS use on outcomes in COPD patients from the TIOSPIR™ trial
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015
Evaluation of mucociliary clearance‘s (MCC) condition in patients with COPD. Influence of tiotropium bromide (TB) on MCC
Source: Annual Congress 2007 - Treatment of COPD
Year: 2007
Changes in inhalation therapy after combined assessment of COPD
Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction
Year: 2015
Physical status and dependence levels in patients with COPD exacerbation
Source: International Congress 2014 – Physical activity, exercise and physiotherapy in patients with COPD
Year: 2014
Characteristics and prognostic factors associated with cardiovascular (CV) comorbidity in COPD patients hospitalized for acute exacerbation (AECOPD)
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
Change in the COPD assessment test (CAT) score as predictor of short-term evolution of patients admitted for an exacerbation of COPD
Source: International Congress 2014 – COPD: points to ponder
Year: 2014
Surfactant protein D (SPD) like marker of effectiveness in patients (pts) with acute exacerbations (AE) of COPD ofphosphatidylcholine treatment outcomes
Source: International Congress 2015 – Different data in COPD
Year: 2015
The impact of stepwise withdrawal of inhaled corticosteroids on lung function in COPD patients receiving dual bronchodilation: WISDOM study
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014
Effect of salmeterol/fluticasone propionate
versus
tiotropium bromide on withdrawal rate, health status, lung function and mortality: INSPIRE (investigating new standards for prophylaxis in reduction of exacerbations) study
Source: Eur Respir J 2007; 30: Suppl. 51, 34s
Year: 2007
Influence of tiotropium bromide (TB) on mucociliary clearance (MCC) in patients with COPD
Source: Annual Congress 2009 - Healthcare and treatment of COPD
Year: 2009
COPD on anti-GERD therapy remains at higher risk for severe exacerbation
Source: International Congress 2014 – COPD exacerbations
Year: 2014
COPD assessment test (CAT) in acute exacerbation of COPD and in the long term follow up of COPD patients
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013
The adherence to inhaled drugs in COPD patients: Effect on survival
Source: International Congress 2015 – Treatment and control of respiratory disease
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept